Integer Holdings Corp

Integer Holdings Corp. is a U.S.-based contract development and manufacturing organization focused on medical devices for cardio and vascular, neuromodulation, and cardiac rhythm management markets. It designs and manufactures custom components, assemblies, and system/device solutions for large multinational OEMs, combining engineering, manufacturing, and quality systems under brands such as Greatbatch Medical and Lake Region Medical.

19,0 %

27,0 %

5,5 %

+8,0 %

3.32

2.23

— Integer Holdings Corp
%
Cardio and Vascular CDMO40% Custom components, assemblies, and manufacturing services for cardiovascular devices.
Neuromodulation CDMO20% Manufacturing and engineering support for neuromodulation device platforms.
Cardiac Rhythm Management CDMO20% Production of components and assemblies used in rhythm management devices.
System and Device Solutions10% Ready-to-market device solutions developed with OEM customers.
Engineering and Value-Added Services10% Design, materials selection, process engineering, and program support.

Integer sells primarily to large multinational medical device OEMs and their affiliated subsidiaries, with direct sales...

  • Large multinational medical device OEMsprimary

    Buy custom components, assemblies, and device solutions for branded medical devices; they value scale, quality, and regulatory execution.

  • OEM subsidiaries and operating unitsprimary

    Source products through affiliated entities and regional programs, often tied to global supply agreements.

  • Cardio and vascular device manufacturersprimary

    Buy specialized manufacturing for cardiovascular therapies and related components.

  • Neuromodulation device manufacturerssecondary

    Buy manufacturing and engineering support for implantable and therapy-delivery platforms.

  • Cardiac rhythm management manufacturerssecondary

    Buy components and assemblies used in pacemakers and related rhythm management products.

Integer is headquartered in Plano, Texas and sells globally, but its customer base is heavily tied to U.S...

  • Headquartered in Plano, Texas
  • Approximately 53% of products sold were shipped to U.S. locations in 2025
  • Sales outside the U.S. are still often tied to U.S.-headquartered OEMs
  • Global customer programs require cross-border manufacturing and logistics
  • Geographic mix affects exposure to customer demand shifts and supply-chain risk

Integer is shifting toward higher-growth medtech markets where it has differentiated engineering and manufacturing...

01
Expand in targeted growth medtech marketsmedium-term

These markets offer stronger long-term demand and fit Integer's engineering and manufacturing strengths.

02
Pursue tuck-in acquisitionsshort-term

Acquisitions add capabilities, brands, and technologies that deepen customer relationships and broaden the platform.

03
Increase long-term OEM agreementsshort-term

Longer contracts help secure the revenue base and improve visibility in a concentrated customer model.

Integer's biggest risk is customer concentration: a small number of OEMs account for a large share of revenue, so...

high

Customer concentration

Top three customers were about 49% of 2025 sales, so loss or reduction of one account would materially affect revenue.

Scope
Abbott Laboratories, Boston Scientific, Medtronic
Materiality
High
high

Pricing pressure

OEM customers can demand price reductions, which can reduce operating margins in a contract manufacturing model.

Scope
Contract renewals and annual pricing negotiations
Materiality
High
medium

Customer inventory and sourcing changes

Inventory rebalancing, vertical integration, or alternate supply arrangements can reduce shipments unexpectedly.

Scope
Program-level demand volatility
Materiality
High
medium

Cybersecurity and IT disruption

A breach or outage could interrupt manufacturing, expose data, or trigger regulatory and legal costs.

Scope
Operations, customer data, third-party vendors
Materiality
Medium
medium

Acquisition integration risk

Recent acquisitions must be integrated without disrupting operations or eroding expected synergies.

Scope
Precision, VSi, Biocoat assets
Materiality
Medium
Inventory valuation
Can change gross margin and earnings if demand shifts or products become unsaleable
Acquisition accounting and goodwill
Affects amortization expense, goodwill balance, and future impairment charges
Convertible notes and capped call transactions
Affects interest expense, equity classification, and diluted EPS
Revenue recognition and shipment timing
Can create quarterly volatility in revenue and margins

: 28.4.2026